Join the club for FREE to access the whole archive and other member benefits.


Platform technology for early detection of dementia.

Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease. Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.

Visit website:




Details last updated 17-May-2021

Cognetivity is also referenced in the following:

Hacking your health

BBC Click meets biohackers and companies who believe it will be possible to live on to well beyond 100

People at Cognetivity

Sina Habibi

CEO at Cognetivity Ltd

Thomas Sawyer

Chief Operating Officer at Cognetivity Neurosciences.

Cognetivity News

OptiMind app designed for early diagnosis of dementia with simple tapping

Wired - 11-Nov-2021

A 5-minute test can assess the early risk of getting dementia

Topics mentioned on this page:
Mental Health, Alzheimer's Disease